P251 Safety/tolerability of human immune globulin subcutaneous, 20% in pediatric patients with primary immunodeficiency diseases
| Autor: | Paris, K., Dérfalvi, B., Hussain, I., Haddad, E., Dicso, F., Darter, A., Doralt, J., Engl, W., McCoy, B., Yel, L. |
|---|---|
| Zdroj: | In Annals of Allergy, Asthma & Immunology November 2016 117(5) Supplement:S97-S97 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|